Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta

Preeclampsia (PE) is one of the commonest causes for maternal and fetal morbidity and mortality. Imbalances of angiogenic factors, oxidative stress, and inflammatory response have a role in the pathogenesis of PE. Data regarding the circulating apelin level and its role in PE remains controversial....

Full description

Saved in:
Bibliographic Details
Main Authors: Reham Z. Hamza, Abdel Aziz A. Diab, Mansour H. Zahra, Ali K. Asalah, Suzan M. M. Moursi, Najah M. Al-Baqami, Fawziah A. Al-Salmi, Mai S. Attia
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2021/5017362
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567945705816064
author Reham Z. Hamza
Abdel Aziz A. Diab
Mansour H. Zahra
Ali K. Asalah
Suzan M. M. Moursi
Najah M. Al-Baqami
Fawziah A. Al-Salmi
Mai S. Attia
author_facet Reham Z. Hamza
Abdel Aziz A. Diab
Mansour H. Zahra
Ali K. Asalah
Suzan M. M. Moursi
Najah M. Al-Baqami
Fawziah A. Al-Salmi
Mai S. Attia
author_sort Reham Z. Hamza
collection DOAJ
description Preeclampsia (PE) is one of the commonest causes for maternal and fetal morbidity and mortality. Imbalances of angiogenic factors, oxidative stress, and inflammatory response have a role in the pathogenesis of PE. Data regarding the circulating apelin level and its role in PE remains controversial. This study was formulated to assess the serum apelin level in PE, investigate its correlation with some inflammatory, oxidative stress, and angiogenic proteins in a nitric oxide synthase inhibitor; the N (gamma)-nitro-L-arginine methyl ester (L-NAME)-induced rat model of PE and determine whether apelin administration could protect against development of PE. 40 healthy adult female albino rats and 10 adult male albino rats were used in this study. The pregnant female rats were randomly divided into three groups: group 1 (normal pregnant group), group 2 (PE-induced group), injected subcutaneously with 75 mg L-NAME/kg bodyweight/day starting from day 9 to 20 of gestation, and group 3 (PE-induced group supplemented with apelin (PE + apelin)); PE induced as before and simultaneously subcutaneously injected with apelin-13 (6 × 10−8 mol/kg bodyweight/twice daily) beginning from day 6 to 20 of gestation. In all groups, blood pressure and urine protein were determined at gestation days (GD) 0, 10, and 18. Moreover, serum apelin, placental growth factor (PLGF), vascular endothelial growth factor (VEGF), soluble fms-like tyrosine kinase-1 (sFlt-1), soluble endoglin (sEng), interferon-gamma (IFN-γ), and interleukin-10 (IL-10) levels and serum superoxide dismutase enzyme (SOD) and catalase (CAT) activities of all groups were estimated at the end of experiment. Placental histopathological examination was also performed. PE-induced rats showed significantly decreased serum apelin levels. Moreover, they showed significantly increased blood pressures, urine proteins, sFlt-1, sEng, and IFN-γ (mean arterial blood pressure, urine proteins, sFlt-1, sEng, and IFN-γ showed significant negative correlations with serum apelin level), but it showed significantly decreased VEGF, PLGF, IL-10, SOD, and CAT (VEGF, PLGF, IL-10, and SOD showed significant positive correlations with serum apelin level). In contrast, exogenous apelin administration significantly ameliorated these parameters together with improvement in the placental histoarchitecture in the apelin-supplemented PE group. This study demonstrated the protective effects of apelin administration on the pathogenesis of PE.
format Article
id doaj-art-7c7cadff1ce244c0bcc3c7b79cfef524
institution Kabale University
issn 1687-8345
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-7c7cadff1ce244c0bcc3c7b79cfef5242025-02-03T01:00:06ZengWileyInternational Journal of Endocrinology1687-83452021-01-01202110.1155/2021/5017362Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on PlacentaReham Z. Hamza0Abdel Aziz A. Diab1Mansour H. Zahra2Ali K. Asalah3Suzan M. M. Moursi4Najah M. Al-Baqami5Fawziah A. Al-Salmi6Mai S. Attia7Biology DepartmentZoology DepartmentZoology DepartmentMedical Physiology DepartmentMedical Physiology DepartmentDepartment of Biological SciencesBiology DepartmentZoology DepartmentPreeclampsia (PE) is one of the commonest causes for maternal and fetal morbidity and mortality. Imbalances of angiogenic factors, oxidative stress, and inflammatory response have a role in the pathogenesis of PE. Data regarding the circulating apelin level and its role in PE remains controversial. This study was formulated to assess the serum apelin level in PE, investigate its correlation with some inflammatory, oxidative stress, and angiogenic proteins in a nitric oxide synthase inhibitor; the N (gamma)-nitro-L-arginine methyl ester (L-NAME)-induced rat model of PE and determine whether apelin administration could protect against development of PE. 40 healthy adult female albino rats and 10 adult male albino rats were used in this study. The pregnant female rats were randomly divided into three groups: group 1 (normal pregnant group), group 2 (PE-induced group), injected subcutaneously with 75 mg L-NAME/kg bodyweight/day starting from day 9 to 20 of gestation, and group 3 (PE-induced group supplemented with apelin (PE + apelin)); PE induced as before and simultaneously subcutaneously injected with apelin-13 (6 × 10−8 mol/kg bodyweight/twice daily) beginning from day 6 to 20 of gestation. In all groups, blood pressure and urine protein were determined at gestation days (GD) 0, 10, and 18. Moreover, serum apelin, placental growth factor (PLGF), vascular endothelial growth factor (VEGF), soluble fms-like tyrosine kinase-1 (sFlt-1), soluble endoglin (sEng), interferon-gamma (IFN-γ), and interleukin-10 (IL-10) levels and serum superoxide dismutase enzyme (SOD) and catalase (CAT) activities of all groups were estimated at the end of experiment. Placental histopathological examination was also performed. PE-induced rats showed significantly decreased serum apelin levels. Moreover, they showed significantly increased blood pressures, urine proteins, sFlt-1, sEng, and IFN-γ (mean arterial blood pressure, urine proteins, sFlt-1, sEng, and IFN-γ showed significant negative correlations with serum apelin level), but it showed significantly decreased VEGF, PLGF, IL-10, SOD, and CAT (VEGF, PLGF, IL-10, and SOD showed significant positive correlations with serum apelin level). In contrast, exogenous apelin administration significantly ameliorated these parameters together with improvement in the placental histoarchitecture in the apelin-supplemented PE group. This study demonstrated the protective effects of apelin administration on the pathogenesis of PE.http://dx.doi.org/10.1155/2021/5017362
spellingShingle Reham Z. Hamza
Abdel Aziz A. Diab
Mansour H. Zahra
Ali K. Asalah
Suzan M. M. Moursi
Najah M. Al-Baqami
Fawziah A. Al-Salmi
Mai S. Attia
Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
International Journal of Endocrinology
title Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
title_full Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
title_fullStr Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
title_full_unstemmed Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
title_short Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
title_sort correlation between apelin and some angiogenic factors in the pathogenesis of preeclampsia apelin 13 as novel drug for treating preeclampsia and its physiological effects on placenta
url http://dx.doi.org/10.1155/2021/5017362
work_keys_str_mv AT rehamzhamza correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta
AT abdelazizadiab correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta
AT mansourhzahra correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta
AT alikasalah correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta
AT suzanmmmoursi correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta
AT najahmalbaqami correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta
AT fawziahaalsalmi correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta
AT maisattia correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta